Abstract
Disease activity of acromegaly can be measured in many ways. Growth hormone (GH) and insulin-like growth factor 1 (IGF1) concentrations are the main biochemical markers used to measure the response to treatment. Both GH and IGF1 have been associated with prognosis, in particular mortality. In this review, we discuss the available parameters to assess disease activity in acromegaly.
| Original language | English |
|---|---|
| Pages (from-to) | 609-614 |
| Number of pages | 6 |
| Journal | Clinical endocrinology |
| Volume | 76 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - May 2012 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'What is active acromegaly and which parameters do we have?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver